DR. SCOTT ALLEN SMALL, M.D.
Neurology at 168 St, New York, NY
License number
New York 193749
Category
Neurology
Type
Neurology
Address
Address
710 W 168Th St, New York, NY 10032
Phone
(212) 305-6939
(212) 305-1145 (Fax)
(212) 305-1145 (Fax)
Personal information
See more information about SCOTT ALLEN SMALL at radaris.comName
Address
Phone
5 S Fowlerhouse Rd, Wappingers Fl, NY 12590
9418 Peregrin Ln, Brewerton, NY 13029
12 Coronet Ln, Plainview, NY 11803
32 Cooper Rd, Millerton, NY 12546
Professional information
Dr. Scott A Small, New York NY - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
Sergievsky Center
630 W 168Th St, New York 10032
(212) 305-9194 (Phone)
710 W 168Th St, New York 10032
(212) 305-6939 (Phone), (212) 305-1145 (Fax)
630 W 168Th St, New York 10032
(212) 305-9194 (Phone)
710 W 168Th St, New York 10032
(212) 305-6939 (Phone), (212) 305-1145 (Fax)
Certifications:
Neurology, 1997
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Columbia University College Of Physicians and Surgeons
Graduated: 1992
Ny and Presby Hp Columbia Campus
UCLA Med Center
Columbia University College Of Physicians and Surgeons
Graduated: 1992
Ny and Presby Hp Columbia Campus
UCLA Med Center
Imaging Correlates Of Neurogenesis With Mri
US Patent:
2009024, Oct 1, 2009
Filed:
Nov 14, 2006
Appl. No.:
12/085156
Inventors:
Scott A. Small - New York NY, US
International Classification:
A61K 49/00, A61K 31/551, A61K 31/519, A61K 31/445, A61K 31/137
US Classification:
424 9361, 514220, 514317, 514649, 51425941
Abstract:
This invention provides a method for treating a mammalian subject afflicted with a disorder associated with reduced neurogenesis in the subject's hippocampal dentate gyrus which comprises administering to the subject a therapeutically effective amount of a compound which increases cerebral blood volume in the subject's hippocampal dentate gyrus by a percentage greater than that by which it increases the cerebral blood volume in the subject's hippocampal CA1 region, thereby treating the subject.
Expression Of Rbap48 In Memory And Aging And Methods Related Thereto
US Patent:
2009025, Oct 8, 2009
Filed:
Oct 19, 2006
Appl. No.:
12/083394
Inventors:
Scott A. Small - New York NY, US
International Classification:
A61K 31/7088, C12P 21/04, C12Q 1/00
US Classification:
514 44 R, 435 711, 435 4
Abstract:
This invention provides a method for increasing the expression of RbAp48 protein in a eukaryotic cell comprising introducing into the cell an agent which specifically increases the expression of RbAp48 protein in the cell. This invention also provides a method for treating a subject afflicted with age-related memory decline comprising administering to the subject a therapeutically effective amount of an agent which specifically increases the expression of RbAp48 protein in the cells of the subject's brain. This invention further provides a method for determining whether an agent causes an increase in the expression of RbAp48 protein. Finally, this invention provides a method for determining whether an agent causes an increase in the activity of RbAp48 protein.
Vps35-Based Assays And Methods For Treating Alzheimer's Disease
US Patent:
2005017, Aug 11, 2005
Filed:
Nov 3, 2004
Appl. No.:
10/980921
Inventors:
Scott Small - New York NY, US
Tae-Wan Kim - Old Tappan NJ, US
Tae-Wan Kim - Old Tappan NJ, US
International Classification:
A61K048/00, C12Q001/68
US Classification:
514044000, 435006000
Abstract:
This invention provides a method for determining whether an agent causes a reduction in the expression of a retromer complex protein. This invention further provides a method for determining whether an agent causes a reduction in the activity of a retromer complex. This invention also provides a method for reducing the expression of a retromer complex protein in a cell. This invention provides a method for treating a subject afflicted with Alzheimer's disease. This invention further provides a pharmaceutical composition as well as an article of manufacture. Finally, this invention provides a method for identifying a potential pathogenic nucleic acid transcript with respect to a brain disorder.
High Resolution Metabolic Brain Imaging
US Patent:
2006000, Jan 12, 2006
Filed:
Nov 3, 2004
Appl. No.:
10/981108
Inventors:
Scott Small - New York NY, US
International Classification:
A61K 49/08
US Classification:
424009360
Abstract:
This invention provides a method for determining whether a subject is afflicted with Alzheimer's disease by comparing the metabolic activity of the subject's hippocampal entorhinal cortex with that of a second region of the subject's brain. This invention further provides a method for determining whether a subject is afflicted with Alzheimer's disease by comparing the metabolic activity of the subject's hippocampal entorhinal cortex determined at a first and second time point. Finally, this invention provides a method for determining the amount of blood in a volume of cerebral tissue in vivo, wherein the volume of tissue is 1 mmor less.